NIGHTSTAR THERAPEUTICS PLC
CIK 0001711675
Revenue (TTM)
—
Q1 Apr 2019
Net Income (TTM)
−$44.87M
−39.3% YoY
Q1 Apr 2019
EPS Diluted (TTM)
—
Q1 Apr 2019
Gross Margin
—
Q1 Apr 2019
Operating Margin
—
Q1 Apr 2019
Net Margin
—
Q1 Apr 2019
Free Cash Flow (TTM)
−$46.34M
Q1 Apr 2019
Cash
$94.51M
Q1 Apr 2019
Total Debt
—
Q1 Apr 2019
Shares Outstanding
33.54M sh
Q1 Apr 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.